Release of CGRP from mouse brainstem slices indicates central inhibitory effect of triptans and kynurenate
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background: CGRP is contained in a substantial proportion of unmyelinated trigeminal neurons innervating intracranial tissues. Previously, we have described a hemisected rodent scull preparation and later the intact trigeminal ganglion to measure stimulated CGRP release from trigeminal afferents. Methods: Here, we establish a preparation for examining CGRP release from central trigeminal terminals using single fresh slices of the mouse medullary brainstem. Results: Basal and stimulated amount of CGRP substantially exceeded the detection level. Experiments were designed as matched pairs of at least six brainstem slices per animal. Stimulation with high potassium induced calcium-dependent and reversible CGRP release. Capsaicin stimulation of TRPV1 provoked concentration-dependent CGRP release. The anti-migraine drug naratriptan did not inhibit capsaicin-induced CGRP release from peripheral terminals but inhibited the release from brainstem slices. The glutamate antagonist kynurenate showed a similar pattern of site-specific inhibition of CGRP release. Conclusions: As observed earlier for other drugs used in the treatment of migraine this indicates that the central terminals in the spinal trigeminal nucleus may be the main site of action. The preparation allows evaluating the trigeminal brainstem as a pharmacological site of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
Rosenfeld, M. G., Mermod, J.-J., Amara, S. G., Swanson, L. W., Sawchenko, P. E., Rivier, J., Vale, W. W., & Evans, R. M. (1983) · Nature · doi:10.1038/304129a0 · Cited by 2,302 · cited 1×
“Shortly after CGRP was discovered [19], its presence in primary sensory afferents [20], and in particular trigeminal neurons was described [21].”
Background
Research works printed but not linked: 60
- Brain SD, Cox HM: Neuropeptides and their receptors: innovative science providing novel therapeutic targets. Br J Pharmacol 2006, 147(Suppl 1):S202-S211. · DOI · Paper page
- Goadsby PJ, Edvinsson L, Ekman R: Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 1988, 23: 193–196. 10.1002/ana.410230214 · DOI · Paper page
- Hoffmann J, Wecker S, Neeb L, Dirnagl U, Reuter U: Primary trigeminal afferents are the main source for stimulus-induced CGRP release into jugular vein blood and CSF. Cephalalgia 2012, 32: 659–667. 10.1177/0333102412447701 · DOI
- Levine JD, Fields HL, Basbaum AI: Peptides and the primary afferent nociceptor. J Neurosci 1993, 13: 2273–2286. · DOI · Paper page
- Franco-Cereceda A, Saria A, Lundberg JM: Ischaemia and changes in contractility induce release of calcitonin gene-related peptide but not neuropeptide Y from the isolated perfused guinea-pig heart. Acta Physiol Scand 1987, 131: 319–320. 10.1111/j.1748-1716.1987.tb08244.x · doi:10.1111/j.1748-1716.1987.tb08244.x
- Perney TM, Hirning LD, Leeman SE, Miller RJ: Multiple calcium channels mediate neurotransmitter release from peripheral neurons. Proc Natl Acad Sci USA 1986, 83: 6656–6659. 10.1073/pnas.83.17.6656 · DOI · Paper page
- Saria A, Gamse R, Petermann J, Fischer JA, Theodorsson-Norheim E, Lundberg JM: Simultaneous release of several tachykinins and calcitonin gene-related peptide from rat spinal cord slices. Neurosci Lett 1986, 63: 310–314. 10.1016/0304-3940(86)90376-9 · DOI · Paper page
- Loyd DR, Sun XX, Locke EE, Salas MM, Hargreaves KM: Sex differences in serotonin enhancement of capsaicin-evoked calcitonin gene-related peptide release from human dental pulp. Pain 2012, 153: 2061–2067. 10.1016/j.pain.2012.06.018 · DOI
- Ebersberger A, Averbeck B, Messlinger K, Reeh PW: Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro. Neuroscience 1999, 89: 901–907. 10.1016/S0306-4522(98)00366-2 · DOI · Paper page
- Eberhardt M, Hoffmann T, Sauer SK, Messlinger K, Reeh PW, Fischer MJ: Calcitonin gene-related peptide release from intact isolated dorsal root and trigeminal ganglia. Neuropeptides 2008, 42: 311–317. 10.1016/j.npep.2008.01.002 · DOI
- Amrutkar DV, Ploug KB, Hay-Schmidt A, Porreca F, Olesen J, Jansen-Olesen I: mRNA expression of 5-hydroxytryptamine 1B, 1D, and 1 F receptors and their role in controlling the release of calcitonin gene-related peptide in the rat trigeminovascular system. Pain 2012, 153: 830–838. 10.1016/j.pain.2012.01.005 · DOI
- Tringali G, Greco MC, Capuano A, Guerriero G, Curro D, Navarra P: Flupirtine inhibits calcitonin-gene related peptide release from rat brainstem in vitro. Neurosci Lett 2012, 506: 332–335. 10.1016/j.neulet.2011.11.039 · DOI
- Fischer MJ, Koulchitsky S, Messlinger K: The nonpeptide calcitonin gene-related peptide receptor antagonist BIBN4096BS lowers the activity of neurons with meningeal input in the rat spinal trigeminal nucleus. J Neurosci 2005, 25: 5877–5883. 10.1523/JNEUROSCI.0869-05.2005 · DOI
- Levy D, Burstein R, Strassman AM: Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine. Ann Neurol 2005, 58: 698–705. 10.1002/ana.20619 · DOI · Paper page
- Sixt ML, Messlinger K, Fischer MJ: Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus. Brain 2009, 132: 3134–3141. 10.1093/brain/awp168 · DOI
- Storer RJ, Akerman S, Goadsby PJ: Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol 2004, 142: 1171–1181. 10.1038/sj.bjp.0705807 · DOI · Paper page
- Bretag AH: Synthetic interstitial fluid for isolated mammalian tissue. Life Sci 1969, 8: 319–329. · DOI · Paper page
- Averbeck B, Reeh PW: Interactions of inflammatory mediators stimulating release of calcitonin gene-related peptide, substance P and prostaglandin E(2) from isolated rat skin. Neuropharmacology 2001, 40: 416–423. 10.1016/S0028-3908(00)00171-4 · doi:10.1016/s0028-3908(00)00171-4
- Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM: Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 1982, 298: 240–244. 10.1038/298240a0 · DOI · Paper page
- Uddman R, Edvinsson L, Ekman R, Kingman T, McCulloch J: Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett 1985, 62: 131–136. 10.1016/0304-3940(85)90296-4 · DOI · Paper page
- Ju G, Hokfelt T, Brodin E, Fahrenkrug J, Fischer JA, Frey P, Elde RP, Brown JC: Primary sensory neurons of the rat showing calcitonin gene-related peptide immunoreactivity and their relation to substance P-, somatostatin-, galanin-, vasoactive intestinal polypeptide- and cholecystokinin-immunoreactive ganglion cells. Cell Tissue Res 1987, 247: 417–431. · DOI · Paper page
- Uddman R, Tajti J, Hou M, Sundler F, Edvinsson L: Neuropeptide expression in the human trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2. Cephalalgia 2002, 22: 112–116. 10.1046/j.1468-2982.2002.00324.x · DOI
- McNeill DL, Chung K, Carlton SM, Coggeshall RE: Calcitonin gene-related peptide immunostained axons provide evidence for fine primary afferent fibers in the dorsal and dorsolateral funiculi of the rat spinal cord. J Comp Neurol 1988, 272: 303–308. 10.1002/cne.902720212 · DOI
- Tuchscherer MM, Seybold VS: A quantitative study of the coexistence of peptides in varicosities within the superficial laminae of the dorsal horn of the rat spinal cord. J Neurosci 1989, 9: 195–205. · DOI
- Fischer MJ, Reeh PW, Sauer SK: Proton-induced calcitonin gene-related peptide release from rat sciatic nerve axons, in vitro, involving TRPV1. Eur J Neurosci 2003, 18: 803–810. 10.1046/j.1460-9568.2003.02811.x · DOI
- Capuano A, Curro D, Navarra P, Tringali G: Cortistatin modulates calcitonin gene-related peptide release from neuronal tissues of rat. Comparison with somatostatin. Peptides 2011, 32: 138–143. 10.1016/j.peptides.2010.09.018 · doi:10.1016/j.peptides.2010.09.018
- Jenkins DW, Langmead CJ, Parsons AA, Strijbos PJ: Regulation of calcitonin gene-related peptide release from rat trigeminal nucleus caudalis slices in vitro. Neurosci Lett 2004, 366: 241–244. 10.1016/j.neulet.2004.05.067 · doi:10.1016/j.neulet.2004.05.067
- Garry MG, Hargreaves KM: Enhanced release of immunoreactive CGRP and substance P from spinal dorsal horn slices occurs during carrageenan inflammation. Brain Res 1992, 582: 139–142. 10.1016/0006-8993(92)90328-7 · DOI
- Nanayama T, Kuraishi Y, Ohno H, Satoh M: Capsaicin-induced release of calcitonin gene-related peptide from dorsal horn slices is enhanced in adjuvant arthritic rats. Neurosci Res 1989, 6: 569–572. 10.1016/0168-0102(89)90045-X · DOI
- Samsam M, Covenas R, Ahangari R, Yajeya J, Narvaez JA, Tramu G: Alterations in neurokinin A-, substance P- and calcitonin gene-related peptide immunoreactivities in the caudal trigeminal nucleus of the rat following electrical stimulation of the trigeminal ganglion. Neurosci Lett 1999, 261: 179–182. 10.1016/S0304-3940(98)00989-6 · doi:10.1016/s0304-3940(98)00989-6
- Morton CR, Hutchison WD: Release of sensory neuropeptides in the spinal cord: studies with calcitonin gene-related peptide and galanin. Neuroscience 1989, 31: 807–815. 10.1016/0306-4522(89)90443-0 · DOI · Paper page
- Schaible HG, Ebersberger A, Peppel P, Beck U, Messlinger K: Release of immunoreactive substance P in the trigeminal brain stem nuclear complex evoked by chemical stimulation of the nasal mucosa and the dura mater encephali–a study with antibody microprobes. Neuroscience 1997, 76: 273–284. · doi:10.1016/s0306-4522(96)00353-3
- Morton CR, Hutchison WD: Morphine does not reduce the intraspinal release of calcitonin gene-related peptide in the cat. Neurosci Lett 1990, 117: 319–324. 10.1016/0304-3940(90)90684-2 · doi:10.1016/0304-3940(90)90684-2
- Eftekhari S, Edvinsson L: Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level. BMC Neurosci 2011, 12: 112. 10.1186/1471-2202-12-112 · DOI
- Pauwels PJ, Tardif S, Palmier C, Wurch T, Colpaert FC: How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines. Neuropharmacology 1997, 36: 499–512. 10.1016/S0028-3908(96)00170-0 · DOI
- Hou M, Kanje M, Longmore J, Tajti J, Uddman R, Edvinsson L: 5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase. Brain Res 2001, 909: 112–120. 10.1016/S0006-8993(01)02645-2 · DOI
- Ma QP, Hill R, Sirinathsinghji D: Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats. Eur J Neurosci 2001, 13: 2099–2104. 10.1046/j.0953-816x.2001.01586.x · DOI · Paper page
- Harriott AM, Scheff NN, Gold MS: The complex actions of sumatriptan on rat dural afferents. Cephalalgia 2012, 32: 738–749. 10.1177/0333102412451356 · doi:10.1177/0333102412451356
- Rocha NF, Rios ER, Carvalho AM, Freire LV, Dias ML, de Franca Fonteles MM, de Sousa FC: Synergistic effect of the L-tryptophan and kynurenic acid with dipyrone or paracetamol in mice. Chem Biol Interact 2013, 205: 148–156. 10.1016/j.cbi.2013.07.005 · DOI
- Turski WA, Nakamura M, Todd WP, Carpenter BK, Whetsell WO Jr, Schwarcz R: Identification and quantification of kynurenic acid in human brain tissue. Brain Res 1988, 454: 164–169. 10.1016/0006-8993(88)90815-3 · DOI · Paper page
- Tyce GM: Origin and metabolism of serotonin. J Cardiovasc Pharmacol 1990, 16(Suppl 3):S1-S7. · DOI
- Wolf H: The effect of hormones and vitamin B6 on urinary excretion of metabolites of the kynurenine pathway. Scand J Clin Lab Invest Suppl 1974, 136: 1–186.
- Birch PJ, Grossman CJ, Hayes AG: Kynurenate and FG9041 have both competitive and non-competitive antagonist actions at excitatory amino acid receptors. Eur J Pharmacol 1988, 151: 313–315. 10.1016/0014-2999(88)90814-X · DOI · Paper page
- Knyihar-Csillik E, Toldi J, Krisztin-Peva B, Chadaide Z, Nemeth H, Fenyo R, Vecsei L: Prevention of electrical stimulation-induced increase of c-fos immunoreaction in the caudal trigeminal nucleus by kynurenine combined with probenecid. Neurosci Lett 2007, 418: 122–126. 10.1016/j.neulet.2007.03.007 · DOI
- Knyihar-Csillik E, Mihaly A, Krisztin-Peva B, Robotka H, Szatmari I, Fulop F, Toldi J, Csillik B, Vecsei L: The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus: comparative studies of the effects of SZR-72 and kynurenic acid. Neurosci Res 2008, 61: 429–432. 10.1016/j.neures.2008.04.009 · DOI
- Vamos E, Fejes A, Koch J, Tajti J, Fulop F, Toldi J, Pardutz A, Vecsei L: Kynurenate derivative attenuates the nitroglycerin-induced CamKIIalpha and CGRP expression changes. Headache 2010, 50: 834–843. · DOI
- Sang CN, Ramadan NM, Wallihan RG, Chappell AS, Freitag FG, Smith TR, Silberstein SD, Johnson KW, Phebus LA, Bleakman D, Ornstein PL, Arnold B, Tepper SJ, Vandenhende F: LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine. Cephalalgia 2004, 24: 596–602. 10.1111/j.1468-2982.2004.00723.x · DOI · Paper page
- Tallaksen-Greene SJ, Young AB, Penney JB, Beitz AJ: Excitatory amino acid binding sites in the trigeminal principal sensory and spinal trigeminal nuclei of the rat. Neurosci Lett 1992, 141: 79–83. 10.1016/0304-3940(92)90339-9 · DOI
- Shigemoto R, Ohishi H, Nakanishi S, Mizuno N: Expression of the mRNA for the rat NMDA receptor (NMDAR1) in the sensory and autonomic ganglion neurons. Neurosci Lett 1992, 144: 229–232. 10.1016/0304-3940(92)90756-W · DOI
- Wang MW, Kumar U, Dong XD, Cairns BE: Expression of NMDA and oestrogen receptors by trigeminal ganglion neurons that innervate the rat temporalis muscle. Chin J Dent Res 2012, 15: 89–97.
- Lee J, Ro JY: Differential regulation of glutamate receptors in trigeminal ganglia following masseter inflammation. Neurosci Lett 2007, 421: 91–95. 10.1016/j.neulet.2007.05.031 · doi:10.1016/j.neulet.2007.05.031
- Sahara Y, Noro N, Iida Y, Soma K, Nakamura Y: Glutamate receptor subunits GluR5 and KA-2 are coexpressed in rat trigeminal ganglion neurons. J Neurosci 1997, 17: 6611–6620. · DOI · Paper page
- Kung LH, Gong K, Adedoyin M, Ng J, Bhargava A, Ohara PT, Jasmin L: Evidence for glutamate as a neuroglial transmitter within sensory ganglia. PLoS One 2013, 8: e68312. 10.1371/journal.pone.0068312 · DOI
- Lee J, Chung MK, Ro JY: Activation of NMDA receptors leads to phosphorylation of TRPV1 S800 by protein kinase C and A-Kinase anchoring protein 150 in rat trigeminal ganglia. Biochem Biophys Res Commun 2012, 424: 358–363. 10.1016/j.bbrc.2012.07.008 · DOI
- Song JH, Park ES, Han SM, Han SR, Ahn DK, Youn DH: Signal transduction mechanisms underlying group I mGluR-mediated increase in frequency and amplitude of spontaneous EPSCs in the spinal trigeminal subnucleus oralis of the rat. Mol Pain 2009, 5: 50. 10.1186/1744-8069-5-50 · doi:10.1186/1744-8069-5-50
- Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX: The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 2001, 21: 7463–7473. · DOI · Paper page
- Liu L, Chang GQ, Jiao YQ, Simon SA: Neuronal nicotinic acetylcholine receptors in rat trigeminal ganglia. Brain Res 1998, 809: 238–245. 10.1016/S0006-8993(98)00862-2 · DOI
- Ohshiro H, Tonai-Kachi H, Ichikawa K: GPR35 is a functional receptor in rat dorsal root ganglion neurons. Biochem Biophys Res Commun 2008, 365: 344–348. 10.1016/j.bbrc.2007.10.197 · DOI
- Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, Ling L: Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem 2006, 281: 22021–22028. 10.1074/jbc.M603503200 · DOI · Paper page
- Lennerz JK, Rühle V, Ceppa EP, Neuhuber WL, Bunnett NW, Grady EF, Messlinger K: Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 2008, 507: 1277–1299. 10.1002/cne.21607 · DOI · Paper page
Cited by
Current understanding of trigeminal ganglion structure and function in headache
Messlinger, K., & Russo, A. F. (2019) · Cephalalgia · doi:10.1177/0333102418786261 · Cited by 178
Coles, J. A., Myburgh, E., Brewer, J. M., & McMenamin, P. G. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.05.002 · Cited by 123
Zebenholzer, K., Andree, C., Lechner, A., Broessner, G., Lampl, C., Luthringshausen, G., Wuschitz, A., Obmann, S.-M., Berek, K., & Wöber, C. (2015) · The Journal of Headache and Pain · doi:10.1186/s10194-015-0531-7 · Cited by 50
Metadata
- Authors
- Kageneck, C., Nixdorf-Bergweiler, B. E., Messlinger, K., & Fischer, M. J.
- Venue
- The Journal of Headache and Pain
- Published
- 2014-02-08
- Volume
- 15
- Issue
- 1
- Pages
- 7-7
- ISSN
- 1129-2369 (ISSN-L)
- 1129-2377
- OpenAlex
- W2120094905
- Cited by
- 58
- References
- 1
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Release of CGRP from mouse brainstem slices indicates central inhibitory effect of triptans and kynurenate. https://app.cochat.ai/papers/10.1186/1129-2377-15-7
- The paper
- Kageneck, C., Nixdorf-Bergweiler, B. E., Messlinger, K., & Fischer, M. J. (2014). Release of CGRP from mouse brainstem slices indicates central inhibitory effect of triptans and kynurenate. The Journal of Headache and Pain. https://doi.org/10.1186/1129-2377-15-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.